Insider Transactions in Q2 2023 at Provention Bio, Inc. (PRVB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,567,497
-100.0%
|
-
|
|
Apr 27
2023
|
Ashleigh Palmer Director and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,570,050
-100.0%
|
-
|
|
Apr 27
2023
|
Wayne Pisano Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
7,500
-100.0%
|
-
|
|
Apr 27
2023
|
Francisco Leon Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,500,000
-100.0%
|
-
|
|
Apr 27
2023
|
Francisco Leon Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
73,000
-100.0%
|
-
|
|
Apr 27
2023
|
Eleanor Ramos Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
70,000
-100.0%
|
-
|
|
Apr 27
2023
|
Avery W Catlin Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
20,000
-100.0%
|
-
|
|
Apr 21
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
224,617
-100.0%
|
-
|
|
Apr 20
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
202,314
-47.39%
|
-
|
|
Apr 14
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,190,549
-12.34%
|
$52,573,176
$24.32 P/Share
|
|
Apr 14
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
8,879,023
+33.33%
|
$53,274,138
$6.0 P/Share
|
|
Apr 13
2023
|
Francisco Leon Chief Scientific Officer |
BUY
Bona fide gift
|
Indirect |
1,500,000
+95.36%
|
-
|
|
Apr 13
2023
|
Francisco Leon Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
1,500,000
-95.36%
|
-
|
|
Apr 13
2023
|
Avery W Catlin Director |
BUY
Bona fide gift
|
Indirect |
10,000
+50.0%
|
-
|
|
Apr 13
2023
|
Avery W Catlin Director |
SELL
Bona fide gift
|
Direct |
10,000
-50.0%
|
-
|
|
Apr 04
2023
|
Sessa Capital (Master), L.P. > 10% Shareholder |
SELL
Bona fide gift
|
Direct |
218,651
-33.87%
|
-
|